What Happens to Your Overall Health If You Ignore a Sleep Breathing Problem?
Obstructive sleep apnoea (OSA) is not simply a sleep nuisance. When left undiagnosed and untreated, it exposes the body to a nightly cycle of oxygen deprivation, stress hormone surges, and systemic inflammation — with consequences that span almost every major organ system. Below, we break down the evidence.
⚙️ The Underlying Mechanism: Why Untreated OSA Is So Harmful
To understand the risks, it helps to understand what happens physiologically during an apnoeic episode.
The airway collapses partially or completely during sleep
Oxygen levels in the blood fall (intermittent hypoxia)
Carbon dioxide accumulates, triggering a stress response
The brain forces an arousal to restore breathing — often dozens or hundreds of times per night
Each arousal activates the sympathetic nervous system (the “fight or flight” response), surging cortisol and adrenaline
Repeated cycles of hypoxia and reoxygenation induce oxidative stress, systemic inflammation, and endothelial dysfunction — key mechanisms in atherogenesis. Chronic sympathetic activation contributes to sustained hypertension and increased blood pressure variability. These pathophysiological cascades also promote insulin resistance, dyslipidaemia, hypercoagulability, and arterial stiffness, fostering coronary and cerebrovascular events.
This is not a single-system problem. It is a whole-body inflammatory state, repeated every night.
❤️ Cardiovascular Disease
This is the most extensively studied consequence of untreated OSA, and the evidence is unambiguous.
Key findings:
A 2025 systematic review and meta-analysis of prospective cohort studies (>25,000 participants; median follow-up 9 years) found that OSA was associated with a pooled hazard ratio of 1.82 for cardiovascular events (95% CI 1.45–2.28).
OSA increases the risk of heart failure by 140%, the risk of stroke by 60%, and the risk of coronary heart disease by 30%.
OSA is associated with hypertension, arrhythmias, and heart failure. Intermittent hypoxaemia, sympathetic nervous system activation, systemic inflammation, and ventricular remodelling are among the pathophysiological mechanisms linking OSA to cardiovascular disease, all leading to higher oxidative stress and endothelial dysfunction.
Why hypertension is particularly significant:
OSA is a well-recognised, if not the most common, cause of secondary hypertension. One prospective study in patients with untreated OSA found a five-times greater risk of new-onset hypertension compared to those treated with CPAP, after adjusting for apnoea-hypopnoea index, age, and sex.
Summary: Untreated OSA is an independent cardiovascular risk factor — not simply a consequence of other conditions such as obesity. The relationship persists even after controlling for age, sex, BMI, smoking, and diabetes.
🩺 Type 2 Diabetes and Metabolic Dysfunction
The relationship between OSA and metabolic disease is bidirectional and reinforcing.
A structured narrative review of studies published between 2020 and 2024 found that OSA is independently associated with impaired glucose metabolism, increased insulin resistance, and a higher risk of diabetic complications including nephropathy, retinopathy, and neuropathy.
Up to 83% of patients with type 2 diabetes suffer from unrecognised OSA, and increasing severity of OSA is associated with worsening glucose control.
Intermittent hypoxia and sleep fragmentation resulting from OSA cause sympathetic activation, systemic inflammation, and oxidative stress — perturbations that directly alter glucose metabolism and underlie the increased cardiometabolic morbidity observed in OSA populations.
Summary: OSA does not merely co-exist with type 2 diabetes — it actively disrupts glucose metabolism through mechanisms independent of body weight.
🧠 Brain Health: Cognitive Impairment and Mental Health
Untreated OSA does not spare the brain, and some of its neurocognitive effects may be irreversible.
Cognitive impairment:
Nearly 60% of patients with OSA experience impaired cognitive functions, including attention, working memory, and episodic memory, and are susceptible to mood disorders such as depression and anxiety.
In some domains of cognitive function — particularly attention — deficits caused by untreated OSA can be irreversible and show only partial recovery after treatment with CPAP. Untreated OSA can ultimately lead to decline in cognitive functions or even permanent brain damage.
Approximately half of all patients with OSA have some form of memory impairment and are at risk of premature age-related memory decline. OSA is associated with changes in brain morphology and brain network activity, both of which are associated with cognitive impairments.
Depression and mental health:
Intermittent hypoxia drives hypoperfusion and impaired cerebral vasomotor reactivity, leading to the development or progression of cerebral small vessel disease. Hypoxaemia exacerbates these processes, resulting in white matter lesions, white matter integrity abnormalities, and grey matter loss — initiating or amplifying depressive symptoms and cognitive deficits.
Patients with untreated OSA may present to psychiatric clinics with complaints of sleep disturbances, daytime sleepiness, fatigue, increased irritability or agitation, and chronically depressed mood — and in many cases, because symptoms of depression overlap with those of OSA, the underlying sleep disorder is overlooked.
Summary: The brain is a primary target organ of untreated OSA. Cognitive and mood consequences may become established before the patient is aware there is a sleep problem.
🚗 Accident Risk and Occupational Safety
Excessive daytime sleepiness — a cardinal symptom of OSA — carries significant real-world consequences beyond health.
OSA is a chronic health condition associated with serious cardiovascular and metabolic comorbidities, road traffic accidents, decreased work productivity, and mortality.
Untreated OSA may hasten death through heart disease, hypertension, stroke, myocardial infarction, heart failure, cardiac arrhythmia, diabetes, metabolic syndrome, or vehicular or other accident due to sleepiness or other behavioural effects.
In the UK, there are specific DVLA obligations for commercial drivers with diagnosed OSA. Declining a sleep test does not remove the legal or safety risk — it simply means the condition continues undetected and unmanaged.
🔄 A Compounding Risk Profile
It is important to appreciate that these consequences do not exist in isolation. Untreated OSA:
Raises blood pressure → increasing stroke and cardiac risk
Drives insulin resistance → increasing diabetes risk
Sustains systemic inflammation → accelerating cardiovascular disease and periodontal disease
Impairs cognitive function → affecting work, relationships, and safety
Disrupts mood → worsening quality of life and potentially masking the OSA diagnosis itself
Each consequence feeds into the others, creating a progressively worsening health profile that could, in many cases, have been interrupted at the point of diagnosis.
What You Can Do
A home sleep test is a straightforward, non-invasive first step. At Whitland Dental Co, we offer a dedicated sleep medicine pathway — including validated screening using the Epworth Sleepiness Scale and STOP-BANG questionnaire, home sleep testing where indicated, and mandibular advancement device provision for eligible patients.
📞 Book your sleep assessment at whitlanddental.co
References
Bouloukaki, I., Grote, L., & McNicholas, W. T. (2025). Cardiovascular effects of obstructive sleep apnoea and effects of continuous positive airway pressure therapy: Evidence from different study models. ERJ Open Research, 11(2), 00718-2024. https://publications.ersnet.org/content/erjor/11/2/00718-2024
Hong, Y., Pei, C., Hao, L., Xu, K., Liu, F., & Ding, Z. (2024). The study of the relationship between moderate to severe obstructive sleep apnea and cognitive impairment, anxiety, and depression. Frontiers in Neurology, 15, 1363005. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11119744/
Kipngetich, D., et al. (2024). Association between obstructive sleep apnea risk and type 2 diabetes among Emirati adults: Results from the UAE healthy future study. Frontiers in Endocrinology, 15, 1395886. https://pmc.ncbi.nlm.nih.gov/articles/PMC11286458/
Martínez-García, M. A., et al. (2025). Association between obstructive sleep apnea and cardiovascular risk: A systematic review and meta-analysis of prospective cohort studies. Medicina, 61, PMC12654527. https://pmc.ncbi.nlm.nih.gov/articles/PMC12654527/
Mediano, O., et al. (2022). A structured narrative review of the OSA–T2DM axis. Journal of Clinical Medicine, PMC12194640. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12194640/
Mubashir, T., et al. (2024). Impact of obstructive sleep apnea on cardiovascular health: A systematic review. Cureus, PMC11575733. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11575733/
Nadeem, R., et al. (2016). Obstructive sleep apnea is linked to depression and cognitive impairment: Evidence and potential mechanisms. Current Psychiatry Reports, 18(9), 49. https://pmc.ncbi.nlm.nih.gov/articles/PMC5381386/
Slowik, J. M., & Collen, J. F. (2023). Obstructive sleep apnea: Practice essentials, background, pathophysiology. Medscape. https://emedicine.medscape.com/article/295807-overview
Szmyt, J., Szczapa, T., Chyła, M., Bęben, A., & Maciejewska, I. (2026). Obstructive sleep apnea: The expanding role of dental sleep medicine — A systematic review of mandibular advancement devices, treatment efficacy, and occlusal complications. Dentistry Journal, 14(1), 62. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12839549/
Vgontzas, A. N., & Bixler, E. O. (2008). Obstructive sleep apnea and cardiovascular disease: Role of the metabolic syndrome and its components. Journal of Clinical Sleep Medicine, 4(3), 261–272. https://pmc.ncbi.nlm.nih.gov/articles/PMC2546461/
